Skip to search.
 BSE Up 0.64% NSE Up 0.38%

ZIOPHARM Oncology, Inc. (ZIOP)

-NasdaqCM
6.82 Down 0.47(6.45%) 5 May 1:30am
Prev Close:7.29
Open:7.28
Bid:6.78 x 200
Ask:7.24 x 200
1y Target Est:6.00
Beta:2.46121
Earnings Date:5 May - 9 May (Est.)
Day's Range:6.74 - 7.29
52wk Range:4.56 - 14.93
Volume:2,753,720
Avg Vol (3m):2,589,660
Market Cap:888.11M
P/E (ttm):N/A
EPS (ttm):-0.96
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ZIOP at this time.

Comparison

Symbol% ChgMkt Cap
ZIOPDown 6.45%888.11M
IMGNUp 0.98%537.17M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):218.99
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.39
Quarterly EPS Est (Mar-16) :-0.08
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ZIOPHARM Oncology, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing a portfolio of cancer therapies that address unmet medical needs through synthetic immuno-oncology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback